NGM Bio Announces Proposed Offering of Common Stock
January 04, 2021 16:01 ET
|
NGM Biopharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
January 04, 2021 16:01 ET
|
Fate Therapeutics, Inc.
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of...
Columbia Bank Announces The Appointment of Oliver E. Lewis, Jr. to Executive Vice President, Head of Commercial Banking
January 04, 2021 16:01 ET
|
Columbia Financial, Inc.
FAIR LAWN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Columbia Bank is pleased to announce that Oliver Lewis has been appointed to Executive Vice President, Head of Commercial Banking. In his new role,...
Galecto to Take Part in Two Panel Discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
January 04, 2021 16:01 ET
|
Galecto, Inc.
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 04, 2021 16:01 ET
|
X4 Pharmaceuticals
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the...
Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference
January 04, 2021 16:01 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous...
Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:01 ET
|
Rubius Therapeutics
CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Bank OZK Announces Increased Regular Quarterly Dividend
January 04, 2021 16:01 ET
|
Bank OZK
LITTLE ROCK, Ark., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Bank OZK (Nasdaq: OZK) announced its Board of Directors has approved a regular quarterly cash dividend of $0.2775 per common share payable...
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:01 ET
|
Passage Bio
PHILADELPHIA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous...
COVIA HOLDINGS CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Ohio on behalf of those who acquired Covia Holdings Corporation
January 04, 2021 16:00 ET
|
Wolf Haldenstein Adler Freeman & Herz LLP
LEAD PLAINTIFF DEADLINE IS FEBRUARY 8, 2021 NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst